tirzepatide 7mg (weight loss) 7.5 mg/0.5 mL subcutaneous pen injector Mounjaro (Tirzepatide) is administered as a subcutaneous injection once a week How the weight loss drug

Patients should receive concurrent lifestyle counseling emphasizing nutrition, physical activity, and behavioral strategies to optimize outcomes and maintain weight loss long-term

Wells Pharmacy Network distributes certain FDA-approved commercial products that are manufactured by third-party pharmaceutical companies

7,8,9 The 2024 Dao study of 168 first-trimester GLP-1 exposures and the 2024 Cesta study of 938 periconceptional GLP-1 exposures both found no significant increase in major birth defects

In response to the large number of women who have reported becoming pregnant on the shots, Novo Nordisk, which makes Ozempic, established the Wegovy Pregnancy Registry

Assessing Candidate Eligibility for Semaglutide You might be an ideal candidate for the semaglutide weight loss program if you possess a body mass index (BMI) of 30 or more, or a BMI of 27 along with a weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol

Common semaglutide side effects include nausea, constipation, and headaches